Home › NDC Lookup › RxCUI directory › RxCUI 1726313

OnabotulinumtoxinA 100 UNT Injection [Botox Cosmetic] — RxCUI 1726313

Name: OnabotulinumtoxinA 100 UNT Injection [Botox Cosmetic] (RxCUI 1726313)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1726313 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1726313

Official nameOnabotulinumtoxinA 100 UNT Injection [Botox Cosmetic]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asBotox Cosmetic 100 UNT Injection

FDA products mapped2

Package NDCs mapped4

Reported Medicaid activity (SDUD)2,384 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to OnabotulinumtoxinA Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Botox (onabotulinumtoxinA) has a long list of medical uses that go well beyond cosmetics. It's FDA-approved to treat overactive bladder, prevent chronic migraines, reduce muscle st...
I thought Botox was just for wrinkles — what else is it actually used for?
The effects typically last several months — the exact duration depends on what you're being treated for. For most conditions, re-injection is done no sooner than every 3 months, an...
How long do the effects of Botox last, and how often will I need injections?

📖 Read our full OnabotulinumtoxinA Injection guide →

🕸️ Concept Web — How OnabotulinumtoxinA 100 UNT Injection [Botox Cosm... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept OnabotulinumtoxinA 100 UNT Injection [Botox Cosmetic] RxCUI 1726313 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Botulinum toxin type A 1712 IN
- OnabotulinumtoxinA 860189 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Botox Cosmetic 604010 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Botulinum toxin type A Injection 1732153 SCDF
- OnabotulinumtoxinA Injection 2645551 SCDFP
- Botulinum toxin type A Injectable Product 1743429 SCDG
- OnabotulinumtoxinA Injectable Product 2660155 SCDGP
- Botulinum toxin type A Injection [Botox Cosmetic] 1726295 SBDF
- OnabotulinumtoxinA Injection [Botox Cosmetic] 2654472 SBDFP
- Botox Cosmetic Injectable Product 1175723 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- OnabotulinumtoxinA 100 UNT Injection 860192 SCD
- OnabotulinumtoxinA 100 UNT 1726286 SCDC
- OnabotulinumtoxinA 100 UNT [Botox Cosmetic] 1726312 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

OnabotulinumtoxinA 100 UNT Injection SCD · 860192
OnabotulinumtoxinA 100 UNT SCDC · 1726286
Botulinum toxin type A Injection SCDF · 1732153
OnabotulinumtoxinA Injection SCDFP · 2645551
Botulinum toxin type A Injectable Product SCDG · 1743429
OnabotulinumtoxinA Injectable Product SCDGP · 2660155

Brand-Name Concepts

OnabotulinumtoxinA 100 UNT [Botox Cosmetic] SBDC · 1726312
Botulinum toxin type A Injection [Botox Cosmetic] SBDF · 1726295
OnabotulinumtoxinA Injection [Botox Cosmetic] SBDFP · 2654472
Botox Cosmetic Injectable Product SBDG · 1175723
Botox Cosmetic BN · 604010

📦 FDA Products & Package NDCs

2 products · 4 package NDCs

4 package NDCs map to RxCUI 1726313 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00023-3919-50	1 VIAL, GLASS in 1 CARTON (0023-3919-50) / 1 INJECTION, POW...	BOTOX Cosmetic	Allergan, Inc.	2008-07-15
00023-3919-51	1 VIAL, GLASS in 1 CARTON (0023-3919-51) / 1 INJECTION, POW...	BOTOX Cosmetic	Allergan, Inc.	2008-07-15
00023-9232-01	1 VIAL, GLASS in 1 CARTON (0023-9232-01) / 1 INJECTION, POW...	BOTOX Cosmetic	Allergan, Inc.	2008-05-20
00023-9232-02	1 VIAL, GLASS in 1 CARTON (0023-9232-02) / 1 INJECTION, POW...	BOTOX Cosmetic	Allergan, Inc.	2008-05-20

Observed labelers: Allergan, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0585	Injection,onabotulinumtoxina	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.